UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?

JAMA neurology, 2021-07, Vol.78 (7), p.787

2021

Volltextzugriff (PDF)

SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort

JAMA neurology, 2021-07, Vol.78 (7), p.880

2021

Volltextzugriff (PDF)

Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis

Journal of neurology, 2024-08, Vol.271 (8), p.5577-5589

2024

Volltextzugriff (PDF)

The role of CD56bright NK cells in neurodegenerative disorders

Journal of neuroinflammation, 2024-02, Vol.21 (1), p.1-48, Article 48

2024

Volltextzugriff (PDF)

Adipokines in multiple sclerosis patients are related to clinical and radiological measures

Journal of neurology, 2023-04, Vol.270 (4), p.2018-2030

2023

Volltextzugriff (PDF)

Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis

Journal of neurology, 2024-09, Vol.271 (9), p.5958-5968

2024

Volltextzugriff (PDF)

Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination

Nature communications, 2022-05, Vol.13 (1), p.2445-2445, Article 2445

2022

Volltextzugriff (PDF)

Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications

Neurology, 2012-09, Vol.79 (13), p.1369-1376

2012

Volltextzugriff (PDF)

Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional Study

Brain sciences, 2024-01, Vol.14 (1), p.36

2024

Volltextzugriff (PDF)

How Far Are We in Translating the Multiple Sclerosis Prodromes in Clinical Practice?

Neurology, 2023-11, Vol.101 (20), p.873-874

2023

Volltextzugriff (PDF)

Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination

International journal of molecular sciences, 2021-11, Vol.22 (23), p.12634

2021

Volltextzugriff (PDF)

Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11461

2022

Volltextzugriff (PDF)

Tumor Necrosis Factor α Blockers and the Risk of Multiple Sclerosis

Neurology, 2023-02, Vol.100 (6), p.267-268

2023

Volltextzugriff (PDF)

State Changes During Resting-State (Magneto)encephalographic Studies: The Effect of Drowsiness on Spectral, Connectivity, and Network Analyses

Frontiers in neuroscience, 2022-06, Vol.16, p.782474-782474

2022

Volltextzugriff (PDF)

Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination

Frontiers in neurology, 2022-11, Vol.13, p.1032830-1032830

2022

Volltextzugriff (PDF)

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

Multiple sclerosis, 2013-04, Vol.19 (5), p.593-600

2013

Volltextzugriff (PDF)

Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial

Journal of neurology, 2024-04, Vol.271 (4), p.1649-1662

2024

Volltextzugriff (PDF)

Cortical Remyelination Is Heterogeneous in Multiple Sclerosis

Journal of neuropathology and experimental neurology, 2017-05, Vol.76 (5), p.390-401

2017

Volltextzugriff (PDF)

Longitudinal Changes in Cognitive Test Scores in Patients With Relapsing-Remitting Multiple Sclerosis: An Analysis of the DECIDE Dataset

Neurology, 2023-07, Vol.101 (1), p.e1

2023

Volltextzugriff (PDF)

Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis

Neurology, 2024-03, Vol.102 (6), p.e208032

2024

Volltextzugriff (PDF)

The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis

Frontiers in neurology, 2022-08, Vol.13, p.907245-907245

2022

Volltextzugriff (PDF)

The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort

Annals of clinical and translational neurology, 2023-08, Vol.10 (8), p.1268-1283

2023

Volltextzugriff (PDF)

Histone deacetylase gene variants predict brain volume changes in multiple sclerosis

Neurobiology of aging, 2013, Vol.34 (1), p.238-247

2013

Volltextzugriff (PDF)

Association of Polygenic Risk Score With Lifetime Risk of Developing Multiple Sclerosis in a Population-Based Birth-Year Cohort

Neurology, 2024-10, Vol.103 (7), p.e209663

2024

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(71)

Sprache

Englisch
(70)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(65)
Science & Technology
(65)
Neurosciences & Neurology
(60)
Clinical Neurology
(55)
Multiple Sclerosis
(48)
Humans
(43)
Neurosciences
(38)
Female
(18)
Male
(16)
Adult
(15)
Middle Aged
(15)
Magnetic Resonance Imaging
(14)
Multiple Sclerosis - Drug Therapy
(13)
Multiple Sclerosis - Pathology
(12)
Neurology
(10)
Multiple Sclerosis - Diagnostic Imaging
(9)
Disease Progression
(8)
Original Research Papers
(8)
Antibodies
(7)
Atrophy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?

SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort

Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis

The role of CD56bright NK cells in neurodegenerative disorders

Adipokines in multiple sclerosis patients are related to clinical and radiological measures

Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis

Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination

Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications

Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional Study

How Far Are We in Translating the Multiple Sclerosis Prodromes in Clinical Practice?

Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination

Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis

Tumor Necrosis Factor α Blockers and the Risk of Multiple Sclerosis

State Changes During Resting-State (Magneto)encephalographic Studies: The Effect of Drowsiness on Spectral, Connectivity, and Network Analyses

Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial

Cortical Remyelination Is Heterogeneous in Multiple Sclerosis

Longitudinal Changes in Cognitive Test Scores in Patients With Relapsing-Remitting Multiple Sclerosis: An Analysis of the DECIDE Dataset

Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis

The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis

The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort

Histone deacetylase gene variants predict brain volume changes in multiple sclerosis

Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study

Association of Polygenic Risk Score With Lifetime Risk of Developing Multiple Sclerosis in a Population-Based Birth-Year Cohort

Suchergebnisse filtern